Persistent URL of this record https://hdl.handle.net/1887/3563467
In Collections
This item can be found in the following collections:
![Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial](https://scholarlypublications.universiteitleiden.nl/sites/all/themes/scholarly/img/closed_access.png)
Ripretinib Versus Sunitinib in Patients With Advanced Gastrointestinal Stromal Tumor After Treatment With Imatinib (INTRIGUE): A Randomized, Open-Label, Phase III Trial
- All authors
- Bauer, S.; Jones, R.L.; Blay, J.Y.; Gelderblom, H.; George, S.; Schoffski, P.; Mehren, M. von; Zalcberg, J.R.; Kang, Y.K.; Razak, A.A.; Trent, J.; Attia, S.; Cesne, A. le; Su, Y.; Meade, J.; Wang, T.; Sherman, M.L.; Ruiz-Soto, R.; Heinrich, M.C.
- Date
- 2022-12-01
- Journal
- Journal of Clinical Oncology
- Volume
- 40
- Issue
- 34
- Pages
- 3918 - +